Search Results for: human embryo crispr

The Niche weekend reads: Editas mess, The Niche updates, papers

The news of the week relates to an interim clinical trial report from gene-editing firm Editas on its CRISPR trial for a form of vision loss. On to that in a minute. What have you been reading the past week? Below, I include our weekly list of recommended reads. However, first I wanted to give …

The Niche weekend reads: Editas mess, The Niche updates, papers Read More »

What is Wharton’s jelly & its possible clinical uses?

Wharton's jelly umbilical cord H&E

For more than a year in my first job as a scientist I isolated cells from umbilical cord veins and then tossed the tissue away, never realizing there was more there that could be useful in the form of something called Wharton’s jelly. What’s in this article Umbilical cord histology & Wharton’s jelly | What …

What is Wharton’s jelly & its possible clinical uses? Read More »

Recommended reads: ISSCR guidelines pushback, TB outbreak from regen product, pubs

human-embryo-modification

Although in my years as a stem cell biologist I haven’t yet been in a leadership role at the International Society for Stem Cell Research or ISSCR, unproven stem cell clinics have claimed that I somehow speak for ISSCR. I am just a standard member of the group like thousands of other researchers. In fact, …

Recommended reads: ISSCR guidelines pushback, TB outbreak from regen product, pubs Read More »

Recommended reads: jobs, FDA letter, & The Niche new look

the body building fda letter the niche

During the week as I’m doing other stuff I keep my eyes open for interesting things to read, including over the weekend about stem cell research, COVID, CRISPR, and more for The Niche weekly recommended reads. This week a lot was going as we updated The Niche site to our new theme and format. I …

Recommended reads: jobs, FDA letter, & The Niche new look Read More »

Grading my 20 stem cell predictions for 2020

Knoepfler-The-Niche-stem-cell-blog-predictions-2020

Each year I metaphorically try to look into a crystal ball for stem cell predictions for the coming year and I did so for 2020, but the COVID-19 pandemic threw a monkey wrench into my predictions. It actually kind of blew some up. It also raised some interesting questions and dilemmas. For instance, do many …

Grading my 20 stem cell predictions for 2020 Read More »

Stem cell videos

Over the years I’ve done a variety of videos that ended up on YouTube. While most of these were stem cell videos, some deal with other important topics such as CRISPR of human embryos. We now also have a dedicated channel on YouTube The Stem Cell Channel. Check it out and follow for the latest …

Stem cell videos Read More »

20/20 vision? The Niche’s 20 stem cell & regenerative medicine predictions for 2020

The-Niche-stem-cell-predictions-2020

Every year in December and early January I do a post predicting some key events for the stem cell and regenerative medicine field for the upcoming year and today’s post contains my predictions for 2020. You can see my past 2019 predictions along with my grades for them here. I gave myself a B+ for …

20/20 vision? The Niche’s 20 stem cell & regenerative medicine predictions for 2020 Read More »

B+ on my report card on my 20 stem cell predictions for 2019

stem-cell-crystal-ball-predictions-1

Last year around this time I took my annual plunge to make 20 predictions for the coming year for the stem cell and regenerative medicine field. I even made a crystal ball graphic to highlight the complexity of the stem cell ecosystem into which these predictions were embedded (see image) for 2019. How’d I do? …

B+ on my report card on my 20 stem cell predictions for 2019 Read More »

Stem cell good news: novel cancer work, new CA bills, Alzheimer’s, & more pubs

stem-cells-alzheimers

There’s nothing like stem cell good news and interesting publications to perk one up on a Monday. Enjoy. What recent papers have struck you as exciting? Novel stem cell-based cancer approaches (Part 1) It was exciting when Fate Therapeutics got the first induced pluripotent stem cell (IPSC) IND in the U.S. for their IPSC-derived natural killer cell …

Stem cell good news: novel cancer work, new CA bills, Alzheimer’s, & more pubs Read More »